Sci-engi-medco Solutions, Inc.

Saint Charles, MO 63303

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $539K
First Award Date 09/24/14
Most Recent Award Date 09/06/17

Key Personnel

Last Name Name Awards Contact
PANDURANGI RAGHU S PANDURANGI 3
PAULMURUGAN RAMASAMY PAULMURUGAN 2
GABRIELSON KATHLEEN LOUISE GABRIELSON 1
POMPER MARTIN G POMPER 1

3 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-302
Budget: 09/06/17 - 08/31/18

Project Summary/Abstract Chronic cardiotoxicity is a clinically unresolved issue for cancer patients who are treated, particularly with anthracycline based drugs. Currently, triple negative breast cancer (TNBC) patients have no option, but to rely on these nonspecific chemotherapeutics. New technologies are needed to reduce the off-target toxic...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-019
Budget: 07/13/16 - 12/31/16

DESCRIPTION (provided by applicant): Dysregulation of apoptosis pathways and loss of Human Beta Defensin-1 (hBD-1) are the common tactics adapted by cancer cells to circumvent the effects of chemotherapy. Consequently, high dose of chemotherapy is required to obtain a clinically relevant therapeutic index which in turn, compromises safety and de...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic: PA-13-088
Budget: 09/24/14 - 08/31/15

Project Summary/Abstract Dysregulation of apoptosis pathways and loss of Human Beta Defensin-1 (hBD-1) are the common tactics adapted by cancer cells to circumvent the effects of chemotherapy. Consequently, high dose of chemotherapy is required to obtain a clinically relevant therapeutic index which in turn, compromises safety and develops resi...